Do ulcers burn out or burn on? Managing duodenal ulcer diathesis in the Helicobacter pylori era

American Journal of Gastroenterology

Volumn 92, Issue 3, 1997, Pages 387-393

  Neil, Garry A ^a,b  

^a American College of Gastroenterology   (United States)

^b Astra Merck Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; METRONIDAZOLE; PROTON PUMP INHIBITOR; RANITIDINE;

ANTIBIOTIC THERAPY; CLINICAL EXAMINATION; DISEASE ASSOCIATION; DISEASE SEVERITY; DUODENOSCOPY; DUODENUM ULCER; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; PRIORITY JOURNAL; REVIEW; STOMACH ACID;

ACUTE DISEASE; ADULT; AGED; CHRONIC DISEASE; DUODENAL ULCER; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PATIENT SELECTION; RECURRENCE; RISK FACTORS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 0031038285     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (59)

1. Neil GA, Suchower L, Johnson EW, et al. H. pylori (HP) eradication as a Surrogate marker for duodenal ulcer (DU) relapse reduction. Am J Gastroenterol 1995;90:1588 (abstract).
2. DAIDP. Helicobacter pylori-associated peptic ulcer disease-Indication #25. Points to Consider. 1995:1-8.
3. NIH Consensus Development Panel on Helicobacter pylori in peptic ulcer disease. Helicobacter pylori in peptic ulcer disease. JAMA 1994; 272:65-9.
4. Fry J. Peptic ulcer: A profile. Br Med J 1964;2:809-12.
5. Greibe J, Bugge P, Gjørup T, et al. Long-term prognosis of duodenal ulcer: Follow-up and survey of doctors' estimates. Br Med J 1977;2: 1572-4.
6. Tytgat GNJ, Noach LA, Rauws EAJ. Helicobacter pylori infection and duodenal ulcer disease. Gastroenterol Clin North Am 1993;22:127-139.
7. Dorland's illustrated medical dictionary; Philadelphia: W.B. Saunders, 1994.
8. Sonnenberg A. Peptic ulcer. In Everhart JE ed. Digestive diseases in the United States: Epidemiology and impact. NIH Publication No. 94-1447. Washington, DC: U.S. Government Printing Office, 1994: 357-408.
9. Wirsung E. Zr diagnostik und behandlung des magengeschwürs. Arch f Verdauungster 1905;11:200-30.
10. Krause U. Long term results of medical and surgical treatment of peptic ulcer. Acta Chir Scand 1963;125(suppl 310):5-11.
11. Quigstad I, Romcke O. Post-investigation of medically treated gastric and duodenal ulcers. Acta Med Scand 1946;126:34-9.
12. Malmros H, Hiertonn TA. Post-investigation of 687 medically treated cases of peptic ulcer. Acta Med Scand 1949;133:229-52.
13. Krarup NB. On the results of the medical treatment of peptic ulcer. Acta Med Scand 1946;123:181-207.
14. Misiewicz JJ. Peptic ulceration and its correlation with symptoms. Clin Gastroenterol 1978;7:571-82.
15. Burland WL, Hawkins BW, Beresford J. Cimetidine treatment for the prevention of recurrence of duodenal ulcer: An international collaborative study. Postgrad Med J 1980;56:173-6.
16. Silvis SE. Results of the United States ranitidine maintenance trials. Am J Med 1984;77(suppl 5B):33-8.
17. Lee FI, Fielding JD, Holmes GKT, et al. Ranitidine prophylaxis of duodenal ulcer recurrence. Hepato-Gastroenterology 1984;31:85-7.
18. Walan A, Bianchi-Porro G, Hentschel E, et al. Maintenance treatment with cimetidine in peptic ulcer disease for up to 4 years. Scand J Gastroenterol 1987;22:397-405.
19. Lindell G, Celebioglu F, Von Holstein CS, et al. On the natural history of peptic ulcer. Scand J Gastroenterol 1994;29:979-82.
20. Penston JG, Dixon JS, Boyd EJS, et al. Placebo-controlled investigation of duodenal ulcer recurrence after withdrawal of long-term treatment with ranitidine. Aliment Pharmacol Ther 1993;7:259-65.
21. Van Deventer G, Elashoff JD, Reedy TJ, et al. A randomized study of maintenance therapy with ranitidine to prevent the recurrence of duodenal ulcer. N Engl J Med 1989;320:1113-9.
22. Ippoliti A, Elashoff J, Valenzuela J, et al. Recurrent ulcer after successful treatment with cimetidine or antacid. Gastroenterology 1983; 85:875-80.
23. Battaglia G, Di Mario F, Dotto P, et al. The natural history of duodenal ulcer disease. Hepato-Gastroenterology 1992;39:139-43.
24. 2 receptor antagonists change the natural history of duodenal ulcer disease? Am J Gastroenterol 1994;89:3-6.
25. Cargill JM, Peden N, Saunders JHB, et al. Very long-term treatment of peptic ulcer with cimetidine. Lancet 1978;2:1113-5.
26. Gudmand-Høyer E, Jensen KB, Krag E, et al. Prophylactic effect of cimetidine in duodenal ulcer disease. Br Med J 1978;1:1095-7.
27. Dronfield MW, Batchelor AJ, Larkworthy W, et al. Controlled trial of maintenance cimetidine treatment in healed duodenal ulcer: Short-and long-term effects. Gut 1979;20:526-30.
28. Fitzpatrick WJF, Blackwood WS, Northfield TC. Does cimetidine alter subsequent natural history of duodenal ulcer. Gut 1979;20:A905 (abstract).
29. Salera M, Taroni F, Miglioli M, et al. Long-term effects and after-effects of cimetidine in duodenal ulcer patients. Ital J Gastroenterol 1979;11:49-52.
30. Bodemar G, Walan A. Two-year follow-up after year's treatment with cimetidine or placebo. Lancet 1980;1:38-9.
31. Mekel RCPM. Two-year maintenance treatment with cimetidine for duodenal ulcers. S Afr Med J 1980;57:293 (abstract).
32. Rune SJ, Griebe J, Møllman KM, et al. Recurrence of duodenal ulcer pain after treatment with cimetidine for four and eight weeks. Gut 1980;21:151-3.
33. Korman MG, Hetzel DJ, Hansky J, et al. Relapse rate of duodenal ulcer after cessation of long-term cimetidine treatment: A double-blind controlled study. Dig Dis Sci 1980;25:88-91.
34. Webster J, Petrie JC, Griffiths R. A combined clinical pharmacokinetics study of cimetidine in patients with duodenal ulceration. Scott Med J 1980;25:81 (abstract).
35. Bardhan KD, Cole DS, Hawkins BW, et al. Does treatment with cimetidine extended beyond initial healing of duodenal ulcer reduce the subsequent relapse rate? Br Med J 1982;284:621-3.
36. Bardhan KD, for the Anglo-Irish Cimetidine Long-Term Study Group. Six years of continuous cimetidine treatment in peptic ulcer disease: Efficacy and safety. Aliment Pharmacol Ther 1988;2:395-405.
37. Penston J, Wormsley KG. Efficacy and safety of long-term maintenance therapy of duodenal ulcers. Scand J Gastroenterol 1989;24: 1145-52.
38. Holtmann G, Armstrong D, Goebell H, et al. Does long-term maintenance therapy with ranitidine affect the natural course of duodenal ulcer disease? Eur J Gastroenterol Hepatol 1993;5:311-7.
39. Penston JG, Dixon JS, Boyd EJS, et al. A placebo-controlled investigation of duodenal ulcer recurrence after withdrawal of long-term treatment with ranitidine. Aliment Pharmacol Ther 1993;7:259-65.
40. Susi D, Neri M, Ballone E, et al. Five-year maintenance treatment with ranitidine: Effects on the natural history of duodenal ulcer disease. Am J Gastroenterol 1994;89:26-32.
41. Boyd EJS, Penston JG, Johnston DA, et al. Does maintenance treatment keep duodenal ulcers healed? Lancet 1988;1324-7.
42. Boyd EJS, Wilson JA, Wormsley KG. The fate of asymptomatic recurrences of duodenal ulcer. Scand J Gastroenterol 1984;19:808-12.
43. Bianchi-Porro G, Parente F. Long term treatment of duodenal ulcer: A review of management options. Drugs 1991;41:38-51.
44. 2-receptor antagonists for peptic ulcer disease. Aliment Pharmacol Ther 1992;6:3-29.
45. Forbes GM, Glaser ME, Cullen DJE, et al. Duodenal ulcer treated with Helicobacter pylori eradication: Seven year follow-up. Lancet 1994; 343:258-60.
46. Jaspersen D. Helicobacter pylori eradication: The best long-term prophylaxis for ulcer bleeding recurrence? Endoscopy 1995;27:622-5.
47. Graham DY, Hepps KS, Ramirez FC, et al. Treatment of Helicobacter pylori reduces the rate of rebleeding in peptic ulcer disease. Scand J Gastroenterol 1993;28:939-42.
48. Labenz J, Börsch G. Role of Helicobacter pylori eradication in the prevention of peptic ulcer bleeding relapse. Digestion 1994;55:19-23.
49. Rokkas T, Karameris A, Mavrogeorgis A, et al. Eradication of Helicobacter pylori reduces the possibility of rebleeding in peptic ulcer disease. Gastrointest Endosc 1995;41:1-4.
50. Jaspersen D, Koerner T, Schorr W, et al. Helicobacter pylori eradication reduces the rate of rebleeding in ulcer hemorrhage. Gastrointest Endosc 1995;41:5-7.
51. George L, Hyland L, Morgan A, et al. Smoking does not contribute to duodenal ulcer relapse after Helicobacter pylori eradication. Gastroenterology 1990;98:A48 (abstract).
52. El-Omar EM, Penman ID, Ardill JES, et al. Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease. Gastroenterology. 1995;109:681-91.
53. Calam J. Helicobacter pylori, acid and gastrin. Eur J Gastroenterol Hepatol 1995;7:310-7.
54. Katelaris PH, Seow F, Lin BPC, et al. Effect of age, Helicobacter pylori infection, and gastritis with atrophy on serum gastrin and gastric acid secretion in healthy men. Gut 1993;34:1032-7.
55. Collen MJ, Abdulian JD, Chen YK. Age does not affect basal gastric acid secretion in normal subjects or in patients with acid-peptic disease. Am J Gastroenterol 1994;89:712-6.
56. Kekki M, Sipponen, Siurala M. Progression of antral and body gastritis in patients with active and healed duodenal ulcer and duodenitis. Scand J Gastroenterol 1984;19:382-88.
57. Soll AH. Medical treatment of peptic ulcer disease: Practice guidelines. JAMA 1996;275:622-9.
58. Graham DY, Lindsky MD, Cox AM, et al. Long-term nonsteroidal antiinflammatory drug use and Helicobacter pylori infection. Gastroenterology 1991;100:1653-7.
59. Ekström P, Carling L, Wetterhus S, et al. Omeprazole reduces the frequency of gastroduodenal lesions and dyspeptic symptoms during NSAID treatment. Gastroenterology 1995;108:A87 (abstract).